Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory ...
Gemtesa is approved for men with overactive bladder symptoms who are receiving pharmacologic treatment for benign prostatic hyperplasia.
As we enter the new year, all eyes are on the biotech companies awaiting key FDA decisions in January. In 2024, the FDA approved 50 ...
“We are very excited to receive FDA clearance for the innovative SIMEOX 200 therapy ... Forward-Looking Statements This press release contains forward-looking statements within the meaning of the ...
The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).
The Food and Drug Administration is proposing a rule that cosmetic companies would have to take extra steps to ensure that ...
Systane brand eye drops were voluntarily recalled because of possible fungal contamination, the Food and Drug Administration ...
A popular brand of eye drops is being recalled nationwide after a consumer reported a "foreign material" was found in a ...
The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...
The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep ...
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...
The FDA has granted breakthrough therapy designation Trodelvy for adults with extensive-stage small cell lung cancer who ...